Tasermity
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tasermity, covering 2018-03-27 to 2018-03-27. Get the full timeline:
Most recent: EMA Lapsed: Tasermity (sevelamer hydrochloride) — Genzyme Europe BV